KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Pacific Biosciences Of California (PACB) Leases (2017 - 2025)

Pacific Biosciences Of California (PACB) has 8 years of Leases data on record, last reported at $41.7 million in Q4 2025.

  • For Q4 2025, Leases rose 159.12% year-over-year to $41.7 million; the TTM value through Dec 2025 reached $41.7 million, up 159.12%, while the annual FY2025 figure was $41.7 million, 159.12% up from the prior year.
  • Leases reached $41.7 million in Q4 2025 per PACB's latest filing, down from $42.6 million in the prior quarter.
  • Across five years, Leases topped out at $46.6 million in Q4 2021 and bottomed at $16.1 million in Q4 2024.
  • Average Leases over 5 years is $36.0 million, with a median of $39.0 million recorded in 2022.
  • Peak YoY movement for Leases: tumbled 50.63% in 2024, then surged 159.12% in 2025.
  • A 5-year view of Leases shows it stood at $46.6 million in 2021, then decreased by 14.7% to $39.8 million in 2022, then dropped by 18.03% to $32.6 million in 2023, then crashed by 50.63% to $16.1 million in 2024, then soared by 159.12% to $41.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Leases were $41.7 million in Q4 2025, $42.6 million in Q3 2025, and $43.5 million in Q2 2025.